Holen Sie sich die Stockscreener-App
7.26
2.40%
0.17
Handel nachbörslich:
7.18
-0.08
-1.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.09
Offen:
$7.02
24-Stunden-Volumen:
1.75M
Relative Volume:
0.75
Marktkapitalisierung:
$2.00B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
-38.21
EPS:
-0.19
Netto-Cashflow:
$18.24M
1W Leistung:
+5.68%
1M Leistung:
+11.86%
6M Leistung:
+65.38%
1J Leistung:
+83.33%
1-Tages-Spanne:
$7.01
$7.30
1-Wochen-Bereich:
$6.7745
$7.325
52-Wochen-Spanne:
$3.17
$7.325
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
MannKind (NASDAQ:MNKD) Reaches New 1-Year HighHere's What Happened - MarketBeat
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com
MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat
MannKind stock soars to 52-week high, touches $6.93 - Investing.com
MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL
SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily
Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily
Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News
Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily
Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com
Did Mannkind Corp (MNKD) perform well in the last session? - US Post News
Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily
Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News
Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance
MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat
Exploring High Growth Tech Stocks In The United States October 2024 - Yahoo Finance
MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat
MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha
Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News
MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com
More Adults With Type 1 Diabetes Achieved A1C Goal ( - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Bought by Dark Forest Capital Management LP - MarketBeat
Mannkind Corp (MNKD)’s results reveal risk - US Post News
The Attractiveness of Investing In Mind Medicine Inc (MNMD) is Growing - Knox Daily
A new trading data show Mannkind Corp (MNKD) is showing positive returns. - SETE News
MNKD stock rated an Outperform by Leerink Partners - Knox Daily
Closing Figures: Mind Medicine Inc (MNMD)’s Negative Finish at 5.87, Down -1.68 - The Dwinnex
Manba Finance IPO Sees Stellar 73.18 Times Subscription on Second Day - Devdiscourse
Manba Finance IPO subscribed 73.18 times on Day 2 amid heavy demand from institutional investors - NewsDrum
Latest News - LatestLY
Mind Medicine Inc (MNMD) produces promising results - US Post News
Stock market update: Nifty Pharma index advances 0.23% - The Economic Times
Manba Finance IPO continues to attract great interest, subscribed 73 times on day 2 - Moneycontrol
Manba Finance IPO subscribed 56 times so far on Day 2 - Indiainfoline
Manba Finance IPO Day 2: Issue subscribed 41.11 times so far, check key dates and more - Upstox
Manaba Finance IPO Day 2: Check latest subscription, expected listing gains - India Today
Mankind Pharma To Raise Rs 7,000-Crore Debt For Bharat Serums Acquisition - NDTV Profit
Stock to buy today: Mankind Pharma (₹2,651.30): BUY - BusinessLine
Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on... - Moneycontrol
Avoro Capital Advisors LLC Reduces Stock Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Manba Finance Limited IPO Subscribed 23.67 Times on Day 1 of Bidding, Sale To Conclude on September 25; - LatestLY
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):